PMID-sentid	Pub_year	Sent_text	comp_official_name	comp_offset	protein_name	organism	prot_offset
28719824-5	2017	The proportion of oocytes at metaphase II was significantly higher in the l-carnitine-treated MMC than that in the l-carnitine-treated MLC oocytes.	Carnitine	115-126	MLC	Bos taurus	135-138
28719824-6	2017	However in comparison with the untreated controls, the proportion of MII oocytes with mitochondrial clusters was significantly higher only in the l-carnitine-treated MLC oocytes, which also showed a significantly lower mean lipid content.	Carnitine	146-157	MLC	Bos taurus	166-169
28719824-7	2017	The l-carnitine-treated MLC oocytes showed significantly higher fertilization and syngamy rates than the untreated MLC oocytes.	Carnitine	4-15	MLC	Bos taurus	24-27
28719824-9	2017	Although no significant differences in cleavage on Day 2 were found among all oocyte categories, l-carnitine treatment resulted in a significantly higher blastocyst yield in the MLC oocytes on Day 7 and Day 8 and a significantly higher proportion of expanded blastocysts in relation to the total number of blastocysts in MMC oocytes on Day 8.	Carnitine	97-108	MLC	Bos taurus	178-181
21398595-6	2011	The G6PD blockers 6-aminonicotinamide (6AN; 1 mmol/l) and epiandrosterone (EPI; 100 mumol/l) inhibited KCl-induced increases in G6PD activity, [Ca(2+)](i), Ca(2+)-dependent myosin light chain (MLC) phosphorylation, and contraction.	6-Aminonicotinamide	18-37	MLC	Bos taurus	193-196
21398595-6	2011	The G6PD blockers 6-aminonicotinamide (6AN; 1 mmol/l) and epiandrosterone (EPI; 100 mumol/l) inhibited KCl-induced increases in G6PD activity, [Ca(2+)](i), Ca(2+)-dependent myosin light chain (MLC) phosphorylation, and contraction.	Androsterone	58-73	MLC	Bos taurus	193-196
21398595-6	2011	The G6PD blockers 6-aminonicotinamide (6AN; 1 mmol/l) and epiandrosterone (EPI; 100 mumol/l) inhibited KCl-induced increases in G6PD activity, [Ca(2+)](i), Ca(2+)-dependent myosin light chain (MLC) phosphorylation, and contraction.	Potassium Chloride	103-106	MLC	Bos taurus	193-196
15381032-5	2004	Expression of MLC kinase (MLCK), a Ca2+/calmodulin-dependent protein kinase that phosphorylates MLC at its Ser-19 and Thr-18 residues, was determined by RT-PCR and Western blotting.	Serine	107-110	MLC	Bos taurus	14-17
15381032-5	2004	Expression of MLC kinase (MLCK), a Ca2+/calmodulin-dependent protein kinase that phosphorylates MLC at its Ser-19 and Thr-18 residues, was determined by RT-PCR and Western blotting.	Threonine	118-121	MLC	Bos taurus	14-17
15381032-7	2004	MLC phosphorylation was assessed by urea-glycerol gel electrophoresis followed by immunoblotting.	Urea	36-40	MLC	Bos taurus	0-3
15381032-7	2004	MLC phosphorylation was assessed by urea-glycerol gel electrophoresis followed by immunoblotting.	Glycerol	41-49	MLC	Bos taurus	0-3
15381032-16	2004	Under both basal conditions and in the presence of thrombin, MLC phosphorylation was prevented by chelerythrine (10 microm) and Y-27632 (<25 microm).	chelerythrine	98-111	MLC	Bos taurus	61-64
15381032-16	2004	Under both basal conditions and in the presence of thrombin, MLC phosphorylation was prevented by chelerythrine (10 microm) and Y-27632 (<25 microm).	Y 27632	128-135	MLC	Bos taurus	61-64